Relationship between Radiological Lung Findings and Laboratory Ferritin and D-Dimer Levels in Patients with COVID-19 Infection
- 1 Department of Laboratory Medicine, Dr. Sulaiman Al Habib Hospital—ARRYAN, Riyadh, Saudi Arabia
- 2 Department of Laboratory Medicine, Dr. Sulaiman Al Habib Hospital—ARRYAN, Riyadh, Saudi Arabia
- 3 Department of Laboratory Medicine, Dr. Sulaiman Al Habib Hospital—ARRYAN, Riyadh, Saudi Arabia
- 4 Department of Laboratory Medicine, Dr. Sulaiman Al Habib Hospital—ARRYAN, Riyadh, Saudi Arabia
- 5 Department of Laboratory Medicine, Dr. Sulaiman Al Habib Hospital—ARRYAN, Riyadh, Saudi Arabia
- 6 Department of Laboratory Medicine, Dr. Sulaiman Al Habib Hospital—ARRYAN, Riyadh, Saudi Arabia
- 7 Department of Laboratory Medicine, Dr. Sulaiman Al Habib Hospital—ARRYAN, Riyadh, Saudi Arabia
- 8 Department of Laboratory Medicine, King Saud Medical City, Riyadh, Saudi Arabia
Abstract
Introduction: Pulmonary symptoms of COVID-19 infection range from asymptomatic infection to severe pneumonia. Pathogenesis and severity of symptoms were found to be related to the body’s immune response. Objectives: Ferritin and D-Dimer in COVID-19 confirmed cases can predict lung injury and possible poor patient prognosis. Materials and Methods: Patients who had been admitted to Dr. Sulaiman Alhabib-Arryan Hospital with positive COVID-19 polymerase chain reaction (PCR) tests between March 2020 and December 2021 were studied for blood ferritin and D-Dimer levels in relation to pulmonary radiological findings. Results: A total of 494 cases are included in this study. Male patients represent 74.1% of the cases, and the mean age is 51.68 ± 13.37 years. Increased age, ferritin, D-Dimer levels, and respiratory symptoms are factors that showed a statistically significant association with positive computed tomography (CT) findings. Receiver operator characteristic curve (ROC) showed that ferritin has a higher capability than D-Dimer to detect CT findings and that both are equal in predicting possible patient mortality. Suggested cutoff values for Ferritin > 336 ng/mL, with 78.21% sensitivity and 86.42% specificity and for D-Dimer > 0.55 mg/L FEU, with sensitivity of 74.82% and specificity of 75.31%. For mortality, the suggested cutoff point for ferritin is >864.6 ng/mL, which gives a sensitivity of 80.26 and a specificity of 64.83%. The suggested cutoff point for D-Dimer is >1.46 mg/L FEU, which gives a sensitivity of 65.79% and a specificity of 78.23%. Conclusion: Laboratory markers such as Ferritin and D-Dimer can be an accurate predictor of lung injury in COVID-19 patients and their increased values can predict the poor patient prognosis and possible mortality if aggressive hospital care is not provided.
- Huang, C. et al. (2020) Clinical Features of Patients Infected with the 2019 Novel Coronavirus in Wuhan China. Lancet. 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
- Zhou, F. et al. (2020) Lancet Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet 395, 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
- Alunno, A., Carubbi, F. and Rodriguez-Carrio, J. (2020) Storm, Typhoon, Cyclone or Hurricane in Patients with COVID-19? Beware of the Same Storm that Has a Different Origin. RMD Open, 6, e001295. https://doi.org/10.1136/rmdopen-2020-001295
- Robba, C., Battaglini, D., Pelosi, P., et al. (2020) Multiple Organ Dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Review of Respiratory Medicine, 14, 865-868. https://doi.org/10.1080/17476348.2020.1778470
- Conti, P. et al. (2020) Induction of Pro-Inflammatory Cytokines (IL-1 and IL-6) and Lung Inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-Inflammatory Strategies. Journal of Biological Regulators and Homeostatic Agents, 34, 327-331.
- Fan, B. E. et al. (2020) Hematologic Parameters in Patients with COVID-19 infection. American Journal of Hematology, 95, E131-E134. https://doi.org/10.1002/ajh.25847
- Wang, D. Hu, B., et al. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan. China. JAMA, 323, 1061-1069. https://doi.org/10.1001/jama.2020.1585
- Mehta, P., McAuley, D. F., & Brown, M., et al. (2020) HLH across Specialty Collaboration, UK. COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet, 395, 1033-1034. https://doi.org/10.1016/S0140-6736(20)30628-0
- Zhou, F. et al. (2020) sLancet Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet, 395, 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
- El Homsi, M., Chung, M., et al. (2020) Review of Chest CT Manifestations of COVID-19 Infection. European Journal of Radiology Open, 7, 100239. https://doi.org/10.1016/j.ejro.2020.100239
- Yilmaz, A., Sabirli, R., Seyit, M., et al. (2021) Association between Laboratory Parameters and CT Severity in Patients Infected with Covid-19: A Retrospective, Observational Study. The American Journal of Emergency Medicine, 42, 110-114. https://doi.org/10.1016/j.ajem.2021.01.040